## XPEV: XPeng Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 2.3% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.2% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($18.49)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Xpeng Shares Rise After Record 2025 Deliveries Surge 126%**
- Source: TradingView — Track All Markets | 20260102T120816 | Bullish | Relevance: 100%
- Xpeng saw its shares rise after reporting record deliveries for 2025, with total shipments increasing by 126% year-over-year to 429,445 units. The electric-vehicle maker also expanded its overseas sales to 60 countries and its self-operated charging network to roughly 3,000 locations. While management noted faster rollouts and international traction, analysts suggest rapid overseas expansion could impact near-term profitability due to mounting costs.

**2. XPeng reports December and Full-Year 2025 deliveries (XPEV:NYSE)**
- Source: Seeking Alpha | 20260101T090911 | Bullish | Relevance: 100%
- XPeng Inc. (XPEV) announced its delivery figures for December and the full year 2025. The company delivered 37,508 vehicles in December 2025, marking a 2% year-over-year increase. For the entire year 2025, XPeng's total deliveries reached 429,445 units, demonstrating a substantial 126% increase over the previous year.

**3. XPeng (XPEV) climbs 4% ahead of Q4, December delivery update**
- Source: MSN | 20251231T130952 | Bullish | Relevance: 100%
- XPeng (XPEV) saw its stock climb 4% in premarket trading, anticipating its Q4 and December delivery updates. The move reflects market optimism surrounding the electric vehicle manufacturer's upcoming performance reports.

**4. Cybin, Xpeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session**
- Source: Benzinga | 20251231T130952 | Somewhat-Bearish | Relevance: 100%
- U.S. stock futures were generally lower on Wednesday morning, with several individual stocks experiencing significant drops in pre-market trading. Cybin Inc. fell sharply after launching a $100 million equity program. Other companies like Jefferson Capital Inc., SMX (Security Matters) PLC, Corcept Therapeutics Inc., NovaBay Pharmaceuticals Inc., Americas Gold and Silver Corporation, Xpeng Inc., B&G Foods Inc., and Hecla Mining Co. also saw their shares decline before the market opened.

**5. Tangible book value per share of XPeng, Inc. ADR Sponsored Class A – BX:XPEV**
- Source: TradingView — Track All Markets | 20251231T090952 | Neutral | Relevance: 100%
- This article provides the title of a financial metric, "Tangible book value per share," for XPeng, Inc. ADR Sponsored Class A (BX:XPEV). It indicates that the information is available on TradingView, covering various financial aspects. The content primarily lists navigation and footer sections, with the core data point simply being the title of the metric.

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 13.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 5 |

**Top Holders:**
- Alibaba Group Holdin: 4.3% (0.0%)
- TMT General Partner : 3.3% (-0.4%)
- Primecap Management : 1.8% (-3.7%)
- UBS Group AG: 1.3% (+23.8%)
- Marshall Wace LLP: 0.7% (+244.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.36 indicates undervaluation relative to growth. Revenue growth strong at 43% YoY. Institutional flow bullish (3 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $19.5B |
| Beta | 1.05 |
| 52W Range | $11.61 - $28.23 |
| Short Interest | 4.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.36 |
| Forward P/E | 7.8 |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_10 deteriorating from 6.5% to 2.3% (-4.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 0.7pp (needs >3.0% for momentum thesis). MRS_5 (-0.4%) diverging from MRS_10 - short-term weakness emerging. Outperforming sector by 3.5pp, stock-specific strength. Below SMA200 (1.00x), long-term trend not supportive. RSI neutral at 50. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.30% (CS: 79) | Neutral |
| RSI_14 | 50.5 | Neutral |
| MACD Histogram | 0.28 | Bullish |
| vs SMA20 | 1.038x | Above |
| vs SMA50 | 0.952x | Below |
| vs SMA200 | 0.998x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $20.43
- **Stop Loss:** $18.49 (9.5% risk)
- **Target:** $22.37 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 309
- **Position Value:** $6,312.87
- **Portfolio %:** 6.31%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-03-17 (Est: $0.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.47 | $-0.16 | +65.8% |
| 2025Q2 | $-1.06 | $-0.41 | +61.4% |
| 2025Q1 | $-1.51 | $-0.45 | +70.2% |
| 2024Q4 | $-1.45 | $-1.47 | -1.6% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_10*